Helga Zharov
General Counsel presso ALVOTECH
Patrimonio netto: - $ in data 31/03/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Vilhelm Wessman | M | 54 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 12 anni |
Richard Davies | M | 62 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 8 anni |
Linda McGoldrick | M | 69 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 2 anni |
Ann Merchant | F | 59 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 2 anni |
Faysal Kalmoua | M | 48 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 anni |
Sigridur Elin Gudlaugsdottir | F | - |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | - |
Ming Li | M | 47 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 anni |
Joseph E. McClellan | M | 50 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 5 anni |
Sean Gaskell | M | 42 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 anni |
Anil Okay | M | 38 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 6 anni |
Kristrún Heimisdóttir | F | - |
Reykjavik University
| - |
Joel Morales | M | 46 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 4 anni |
Lisa Graver | F | 53 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 2 anni |
Árni Harðarson | M | 57 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 2 anni |
Unnur Thorsteinsdottir | M | - |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland.
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 24 anni |
Benedikt Stefansson | M | - | 2 anni | |
Tomas Ekman | M | 56 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 5 anni |
Guðbjörg Eggertsdóttir | F | 73 |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland.
Reykjavik University
| - |
Kristín Friðgeirsdóttir | M | 52 |
Reykjavik University
| - |
Frosti Ólafsson | M | 42 |
Reykjavik University
| 10 anni |
Katrín Olga Jóhannesdóttir | F | 62 |
Reykjavik University
| - |
Kristjan Th. Davidsson | M | - |
Reykjavik University
| - |
Thordur Magnusson | M | 75 |
Reykjavik University
| - |
Hjörleifur Pálsson | M | 61 |
Reykjavik University
| 14 anni |
Ingunn Svala Leifsdottir | F | 48 |
Reykjavik University
| - |
Giedrius Zunda | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Lance Thibault | M | 58 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 9 anni |
Earl Collier | M | 76 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 4 anni |
Reem Malki | M | 53 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 1 anni |
Ólöf Jónsdóttir | F | - |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | - |
James R. Beery | M | 83 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 6 anni |
Richard A. Leach | M | - |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland.
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 5 anni |
J. Neal Armstrong | M | 85 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 7 anni |
Magnús Hreggviðsson | M | - |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | - |
Rose-Marie Ohlsson | F | - | 2 anni | |
Sarah Tanksley | F | - | 1 anni | |
Dan Hartman | M | 62 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | - |
Mark Levick | M | 60 | 4 anni | |
Rakel Óttarsdóttir | F | 51 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | 2 anni |
Valdimar Svavarsson | M | 56 |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | 6 anni |
Þórður Emil Ólafsson | M | - |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | - |
Frosti Reyr Rúnarsson | M | - |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | - |
Linda B. Buck | M | 77 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 4 anni |
Hannes Hrólfsson | M | - |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | - |
Rúnar Bachmann | M | - |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | - |
Charles McDermott | M | 52 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 4 anni |
Robert Nelsen | M | 60 |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | 5 anni |
Edward Farmer | M | - |
deCODE Genetics ehf
deCODE Genetics ehf Miscellaneous Commercial ServicesCommercial Services deCODE genetics engages in a biopharmaceuticals company. It provides research services with focus on human genes. The company was founded by K?ri Stef?nsson in August 1996 and is headquartered in Reykjavik, Iceland. | - |
Daniel C. Siu | M | - |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 6 anni |
Peter Goodfellow | M | 72 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 4 anni |
Steinthor Baldursson | M | - |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | - |
Birgit Stattin Norinder | F | 75 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 3 anni |
David A. Eiznhamer | M | 59 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 1 anni |
Göran Albert Ando | M | 75 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | - |
Jakob Sigurðsson | M | 60 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 4 anni |
Hirofumi Imai | M | 60 | 3 anni | |
Hafrun Fridriksdottir | M | 62 | - | |
Kristín Pétursdóttir | F | 59 |
Virding hf
Virding hf Investment ManagersFinance Virding hf provides financial services. It operates through four segments: Asset Management, Capital Markets, Corporate Finance and Private Equity Funds. The Asset Management segment offers asset management services that are tailored to the needs of high net worth individuals, pension funds, NGOs and institutional investors. The segment also offers independent advice and personal assistance. The Capital Markets segment works as intermediaries for investments in a wide variety of asset classes for Iceland´s largest investors and international clients such as corporate, institutional investors, UCITS, pension funds, public entities and other professional investors. The Corporate Finance segment offers its clients a wide range of advisory services including fund raising, corporate and financial restructuring, M&A and company divestitures. The Private Equity Funds segment invests in small to medium-size Icelandic companies with a strong market position and attractive growth potential. The company was founded in 1999 and is headquartered in Reykjavík, Iceland. | 4 anni |
Mark E. Gurney | M | 69 |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | 10 anni |
Sandra Casaca | F | - | 1 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Islanda | 52 | 86.67% |
Lussemburgo | 23 | 38.33% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Helga Zharov
- Contatti personali